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Introduction
Among trace elements, zinc (Zn) is a micronutrient 
influencing growth and affecting the development 
and integrity of the immune system (1). Also, it has 
important  roles  in  physiological  functions  of  the 
human body. It has a critical role for the function 
of  over  300  enzymes  (2).  Furthermore,  it  plays 
an important role in function of the liver. There 
are hepatic and extrahepatic actions for Zn in the 
prevention of alcoholic liver injury (3).
  Zinc  deficiency  has  been  involved  in  the 
pathogenesis  of  a  number  of  clinical  findings  in 
chronic  liver  disease.  These  include  the  possible 
role  of  Zn  deficiency  in  the  pathogenesis  of 
hepatic encephalopathy, by inducing alterations in 
urea metabolism (4). In a study, Gur et al. reported 
decreased level of plasma zinc in cirrhotic patients 
due to hepatitis B (5). Hepatitis B and hepatitis C 
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Background and Aims: Zinc (Zn) has various significant roles in physiological functions of the liver. Furthermore, it has 
been reported that the administration of zinc has an important role in pharmacotherapy of viral hepatitis. Cirrhotic 
patients with decrease in plasma zinc level have been covered in previous studies. It is seemingly necessary to assess 
the zinc level, in Iranian cirrhotic patients, as a distinct population, Because of the large phytate amounts in Iranians 
diet. Regarding to etiology, disease progress, and treatment, there are some differences in the 2 most common causes 
of cirrhosis in the Iranian population (hepatitis B and hepatitis C) and it is possible that the zinc level may be different 
between the two. This study was done to shadow some lights on the subject. 
Methods: Between April 2008 and November 2008, plasma zinc level was determined, by atomic absorption method, in 
60 cirrhotic inpatients treated due to hepatitis B or hepatitis C in Talighani hospital (a referral center for gastrointestinal 
and liver diseases in Tehran, Iran). 
Results: Mean ± standard deviation (SD) plasma zinc levels determined 0.34±0.22 mg/L and 0.37±0.22 mg/L in hepati-
tis B and hepatitis C patients respectively. Analysis of t-test showed there is no significant difference between 2 groups 
regarding to plasma zinc level (P = 0.745).
Conclusions: It is concluded that zinc level of studied cirrhotic patients is less than half of the normal range. Moreover, 
there is no difference in plasma zinc level between cirrhotic patients due to hepatitis B or hepatitis C. Regarding to this 
result, supplementation with complementary zinc, may be recommended in both groups in order to optimize the nutri-
tional support and probably better the treatment response.
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are the most common causes of liver cirrhosis in 
many countries like Iran (6). As nutritional habits are 
different among various populations, it is logical to 
determine Zn level in Iranian cirrhotic patients as an 
important trace element. There are some differences 
in  the  etiology,  disease  progress,  prognosis  and 
treatment plan of hepatitis B and C, and it is possible 
that plasma zinc concentration differs in two groups. 
The aims of the present study were 1) determination 
of plasma zinc level in a sample of Iranian cirrhotic 
patients due to hepatitis B or C, 2) to determine if 
there is any difference between plasma zinc levels 
between the 2 groups.
Materials and Methods
In  a  cross  sectional  study,  adult  cirrhotic 
inpatients due to hepatitis B or hepatitis C referred to 
gastrointestinal and liver disease center of Taleghani 
Hospital, Tehran, Iran were enrolled for the study. 
This place is one of the important referral centers 
of liver disease in Iran. Diagnosis of cirrhosis and 
hepatitis were determined by clinical, laboratory and 
liver biopsy from the patients. Exclusion criteria were 
patients who had been co-infected with hepatitis B 
and C and those who had taken a zinc tablet or any 
complementary medicine with zinc in its content. 
Because of the difference in the zinc amount of 
foods, we preferred to select patients nourished with 
a similar regimen prepared by the kitchen of the 
hospital during the study. After informed consent, 
5 cc blood samples were kept from the forearm of 
each patient in fasting state in the morning. Blood 
samples were centrifuged in 5000 rpm for 5 minutes 
and  plasma  was  separated.  Then  plasma  samples 
were kept in the Frazer at the -25 degree centigrade. 
Because the usual method for assessment of zinc 
in  plasma  or  serum  is  the  atomic  absorption  (7), 
we selected the same method for zinc assessment. 
Concentrations of 0.1, 0.3, 0.5 and 0.7 ppm of zinc 
sulfate were prepared as standard samples. Atomic 
absorptions of them were determined for drawing 
standard curve. After completion of 60 samples of 
patients, plasma zinc levels were evaluated by using 
atomic absorption (Perkin Elmer 1100B). 
Results
60  cirrhotic  patients  due  to  hepatitis  B  or 
Hepatitis  C  were  included  in  the  study  during  7 
months (April 2008 to November 2008). Of them 
36 were hepatitis B patients and 24 were hepatitis 
C patients. Demographic data of patients including 
age distribution, sex and smoking habits were shown 
in Table 1. Analysis of chi-square showed that there 
is not any difference between 2 groups regarding to 
sex, age distribution and smoking habits (P = 0.82, 
0.53 and 0.8 respectively).
Mean ± standard deviation (SD) plasma zinc levels 
determined 0.34±0.22 mg/L and 0.37±0.22 mg/L 
in hepatitis B and hepatitis C patients respectively. 
Analysis  of  t-test  showed  that  there  is  not  any 
significant difference between 2 groups regarding to 
plasma zinc level (P = 0.745).
Discussion
Plasma  trace  elements  concentrations  are 
frequently  reported  to  be  a  good  indicator  for 
diagnosis  and  prognosis  of  some  diseases  (8). 
Previous studies showed a decrease in zinc level in 
cirrhotic patients. Pramoolsinsap et al. have stated 
that serum zinc levels were significantly decreased in 
patients with chronic active hepatitis, cirrhosis, and 
hepatocellular carcinoma  (9). Lin et al. announced 
that the zinc concentration in the serum of Chinese 
patients  with  hepatic  cirrhosis  was  significantly 
less than a control group  (10). It should be noted 
that zinc level is usually related to the nutritional 
pattern of each population. It has been shown that 
zinc  deficiency  is  widespread  in  people  living  in 
developing countries like Iranian populations who 
consume rice-based diets (11). The phytate and fiber 
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present in cereal diets can form insoluble complexes 
with zinc leading to its decreased bioavailability (12). 
Since  nutritional  impairment  is  common  in 
cirrhotic patients (13), it seems that determination of 
zinc level in Iranian cirrhotic patients due to hepatitis 
B  and  C  and  comparison  with  a  normal  amount 
of healthy people is necessary as an indicator of 
nutritional status.
Some demographic data may alter zinc plasma 
concentration in human. Lopez et al. reported that 
Serum  Zn  concentrations  were  slightly  higher  in 
men than in women and also there is some elevated 
serum Zn levels in smoking men rather than non 
smokers (14). In the present study, since there is no 
significant difference between the 2 groups regarding 
gender, age distribution and smoking habits, these 
parameters could not lead to biases in interpretation 
of zinc level in both of the groups.
The  results  showed  that  plasma  zinc  levels 
of  both  groups  were  below  the  normal  range  as 
mentioned by the similar investigations (9, 10). There 
are some differences in the normal range of zinc 
in various populations, but a recent study reported 
the normal range of 0.89 ± 0.16 mg/L for plasma 
zinc  in  healthy  volunteers  in  Tehran  (15).  With  a 
comparison result of the present study (0.34±0.22 
mg/L and 0.37±0.22 mg/L) with a range of the 
latter study, it seems that plasma zinc level of the 
cirrhotic patients are less than half of normal values. 
As  nutritional  parameters,  this  study  significantly 
indicates a zinc level deficiency in Iranian cirrhotic 
patients due to hepatitis B or C in comparison with 
healthy volunteers. 
The results of the study are more considerable 
because of the effective role of the zinc supplement 
in pharmacotherapy of viral hepatitis. Yuasa et al. 
have shown that zinc may play an important role 
as a negative regulator of hepatitis C virus (HCV) 
replication in genome-length HCV RNA-replicating 
cells.  They  mentioned  that  zinc  appears  to  offer 
a  novel  approach  to  the  development  of  future 
plans  for  the  treatment  of  intractable  chronic 
hepatitis C (16). Himoto et al. examined the effects 
of polaprezinc, a complex of zinc and L-carnosine, 
on inflammatory activity and fibrosis in the HCV 
infected  patients.  They  reported  that  polaprezinc 
exerts  an  anti-inflammatory  effect  on  the  liver  in 
patients with HCV-related Chronic liver disease by 
reducing iron overload (17).
Based on the result of the study, administration 
of zinc may be recommended for Iranian cirrhotic 
patients due to hepatitis B or C. In future more studies 
recommend for the role of zinc administration on 
clinical,  pathological  status  and  pharmacotherapy 
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